US Cannabis Health

US Cannabis Health is a joint venture established in 2018 by Kali, Inc., Puration, Inc., and Nouveau Life Pharmaceuticals to develop and commercialize cannabis-based pharmaceutical and wellness products. The company utilizes a patented extraction technology originally developed by NCM Biotech to produce high-purity cannabinoid extracts for medical applications. Its business model focuses on forming strategic partnerships with major pharmaceutical companies to integrate these extracts into therapeutic formulations. The venture's pipeline includes candidate products targeting indications such as chronic pain, seizures, and respiratory conditions like COPD. US Cannabis Health aims to bridge the gap between the cannabis industry and mainstream biotechnology through rigorous research and clinical development.